Phage therapy program
Tolka AI Therapeutics
| Status | Provider-listed inquiry route |
|---|---|
| Type | Company |
| Location | Miami, Florida, United States (company office) |
| Entry review | 2026-10-05 |
Access and enquiries
| How to enquire | Published limited expanded-access program accepts inquiries from physicians or patients at expandedaccess@tolka.ai; eligibility requires a treating physician to submit the formal request. |
|---|---|
| Areas of work | Personalized phages for NTM lung disease, initially Mycobacterium abscessus complex; serious/life-threatening disease without viable options, trial ineligibility, favorable assessment, supply and local regulatory/ethical permission. |
| International access | Page mentions local and international regulations but does not enumerate accepted countries or promise cross-border supply. |
What to confirm
- The listed address is a company office, not a confirmed patient treatment location.
- Expanded access requires individual review, a treating physician, available product and applicable regulatory permission. Contact the company to confirm current availability.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | tolka |
|---|